Own Publications

We carry out scientific studies around musculoskeletal diseases such as osteoarthritis. We are experts in the analysis of the quality of life, the needs and perspectives of patients through systematic reviews of the current available bibliography. We also carry out national and international surveys to publicize the patient’s vision of their disease, so that we better understand their situation and develop solutions according to their needs. Likewise, we create and participate in expert roundtables for discussion and the creation of guides and new products for the treatment and improvement of osteoarthritis symptoms.

If you want to receive more information about the publications or are interested in carrying out a study of this type, contact us by writing to: research@oafifoundation.com

Cost-Effectiveness of Chondroitin Sulphate (with or without Glucosamine) Prescription in the Treatment of Knee Osteoarthritis Compared to NSAIDs and COXIBs

Ref: Rubio-Terrés et al. Clinicoecon Outcomes Res. 2026;18:577731

Specialized pro-resolving mediator (SPM)-enriched supplementation modulates inflammatory biomarkers in patients with symptomatic knee osteoarthritis: Blood plasma analysis from the GAUDI study

Ref: Moller et al. Prostaglandins Leukot Essent Fatty Acids. 2026 Jun 10;210:102758.

Actions to Improve the Secondary Prevention of Fragility Fractures in Women with Postmenopausal Osteoporosis: A Social Return on Investment (SROI) Study

Ref: Baquero et al. Revista Internacional de Investigación en Adicciones 2026.12(1): e420

Recommendations for the prevention of fragility fractures: a consensus from international experts and Ibero‑American scientific societies

Ref: Sáez-López et al. Archives of Osteoporosis, 2025, 20:76.

Multidisciplinary consensus on the management of patients with osteopenia and fracture risk in Spain

Ref: Baquero et al. BMC Musculoskeletal Disorders, 2025, 26:970.

Actions to Improve the Secondary Prevention of Fragility Fractures in Women with Postmenopausal Osteoporosis: A Social Return on Investment (SROI) Study

Ref: Olmo-Montes et al. ClinicoEconomics and Outcomes Research 2024:16 889–901

Women show a positive response to platelet‐rich plasma despite presenting more painful knee osteoarthritis than men

Ref: Sánchez et al. Knee Surg Sports Traumatol Arthrosc. 2024 Oct;32(10):2516-2525.

The OARSI Joint Effort Initiative: Priorities for osteoarthritis management program implementation and research 2024–2028

Ref: Bowden et al. Osteoarthritis and Cartilage Open, 2023; 5.

Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain, inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study

Ref: Moller et al. J Transl Med. 2023 Jun 29;21(1):423.

Systematic review of the available literature on psychosocial and individual factors that affect the quality of life of patients with Achilles tendinopathy.

Ref: Verges et al. BMC Musculoskeletal Disorders (2022) 23:1114

Risk of ischemic stroke and use of glucosamine and chondroitin sulfate: A nested case-control study.

Ref: Mazzucchelli et al. Ther. Adv. Musculoskelet. Dis 2022, Vol. 14: 1–16 DOI: 10.1177/ 1759720X221113937

Expert paper on the appropriate use of SYSADOA in controversial clinical situations

Ref: Monfort et al. Reumatol Clin. 2020; 17 (10):595–600.

DOI: 10.1016/j.reuma.2020.06.007

Patients' view of osteoarthritis: Global Osteoarthritis Patient Perception Survey (GOAPPS)

Ref: Vitaloni et al. BMC Musculoskeletal Disorders (2020) 21:727

Global management of patients with knee osteoarthritis begins with life management: a systematic review

Ref: Vitaloni et al. BMC Musculoskeletal Disorders (2019) 20:493

Help us improve the quality of life of Osteoarthritis patients.

OAFI is the International Osteoarthritis Foundation, the first and only foundation aimed exclusively at people with osteoarthritis worldwide.

CONTACT

The Foundation

Actions